Associate Professor

Tel: (901) 523-8990


  • Other, VCU, Richmond, VA, Interventional Cardiology
  • Other, University of Louisville , KY
  • Other, Brigham &Women /Harvard, Boston MA, Research/Imaging fellowship
  • Other, Yale University New Haven CT, Research/Nuclear fellowship
  • Other, Duke University Durham NC, Internal Medicine Residency
  • M.D., Aga Khan University Pakistan, Medicine

Clinical Care Specialty/Interest

Interventional Cardiology


  1. Shah R, McMurray JM, Kober L, Pfeffer MA. Cardiac Structure and Function in Diabetics with Acute Myocardial infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both: the VALIANT Echo Study. JACC. 2007. 49(9); S1: A42-A98..
  2. Chung LH, Shah R, Hou LJ, Yeh HI. Role Of Regional Geometric Dyssynchrony By Real-time Three-dimensional Echocardiography As A Determinant Of Functional Mitral Regurgitation In Patients With Acute Myocardial Infarction. Circulation. 2007;116:II-764..
  3. Morsy M, Slomka T, Shah R. High-volume Forced Diuresis with Matched Hydration Using the RenalGuard System to Prevent Contrast-Induced Nephropathy: A Meta-analysis of Randomized Trials. Cath and Card Interventions 89(Supplement S2):S68 · May 2017..
  4. Shah R.. Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. J Am Coll Cardiol Intv. 2016;9(14):1517-1518.
  5. Shah R.. Invasive Strategy for Acute Coronary Syndrome in The Very Elderly. Lancet 2016.
  6. Shah R, Foody J. Caring for the advanced elderly with acute coronary syndromes. Cardiology Reports. 2006; 8(4): 289-95.
  7. Shah,R. Endothelins in Health and Diseases. Eur J Intern Med. 2007 Jul;18(4):272-82.
  8. Shah R, Wang Y, Masoudi FA, Havranek EP, Foody JM.. Prognosis of troponin only positive myocardial infarction in elderly. Crit Pathways in Cardiol 2006;5: 160-166.
  9. Foody JM, Shah R, Galusha D, Greenspan M, Masoudi FA, Havranek EP, Krumholz HM.. Statins and mortality among elderly patients hospitalized with heart failure.. Circulation. 2006; 113:1086 – 1092..
  10. Shah R. Linagliptin for elderly patients with type 2 diabetes.. Lancet. 2014 Jan 25;383(9914):306-7.
  11. Shah R, Khan, MR.. Comparative safety of vascular closure devices.. Annals of internal Medicine. 2014:160(6):438..
  12. Shah, R.. Renal denervation for resistant hypertension-the Symplicity HTN-1 study.. Lancet.2014; 383(9932):1885.
  13. Shah R, Rashid A, Deam AG.. Dangerous cold Beverages.. Am J Med; 2014. 127(7):e3-4.
  14. Shah R.. Protease-activated receptors in cardiovascular health and diseases.. Am Heart J. 2009 Feb;157(2):253-62.
  15. Shah R.. Pioglitazone vs glimepiride in the PERISCOPE trial. JAMA. 2008 Aug 20;300(7):787-8..
  16. Shah R, Wang Y, Foody JM.. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.. American Journal of Cardiology 2008 Jan 15;101(2):217-222..
  17. Shah R, Wang Y, Foody JM.. Gender and racial difference in the outcomes and guideline-based management of troponin only positive acute myocardial infarction in older persons. Am J Geriatr Cardiology (2006)15;5..
  18. Shah R, Burg MM, Vashist A, Collins D, Liu J, Jadbabaie F, Graeber B, Earley C, Lampert R, Soufer R.. C-reactive protein and vulnerability to mental stress-induced myocardial ischemia.. Molecular Medicine (2006)12;10..
  19. Shah R, Mooney MA.. Complete versus culprit-only revascularisation for ST-segment elevationmyocardial infarction. Heart 2016.
  20. Shah R, Roberts KM, Ramanathan KB.. Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation. JAMA. 2014;311(24):2542..
  21. Shah R. Myocardial ischemic events in 'real world' patients treated with dabigatran.. Am J Med; 2014 Oct;127(10):e19.
  22. Shah R, Matin K.. New oral anticoagulants in patients with atrial fibrillation.. Lancet. 2014;384:23-24.
  23. Shah R, Duncan S. Ramanathan KB.. Cocaine induced ST elevation MI.. Acute Med. 2014;13(2):72-3.
  24. Shah R, Khan MR, Matin K.. Preventive angioplasty in myocardial infarction.. New England J Med 2014;370(3):281.
  25. Shah R, Keough LA, Belalcazar-Portacio A, Ramanathan KB.. Ticagrelor as an alternative in clopidogrel-associated neutropenia.. Platelets. 2014 Jan 16;.
  26. Shah, R. Shelton MR.. Lesson of the month 1: broken heart in the intensive care unit. Clinical Medicine. 2014; 14 (4)..
  27. Shah, R, Nayyar, M, Jovin, IS, Rashid, A, Bondy, BR, Fan, TM, Flaherty, MP, Rao, SV. Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis. Ann Intern Med, 168 (5), 335-342, 2018.
  28. Shah, R. Bioresorbable polymer drug-eluting stents. Lancet, 391 (10124), 935-936, 2018.
  29. Shah, R. Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy. Ann Intern Med, 168 (3), 233-234, 2018.
  30. Shah, R. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. N Engl J Med, 378 (3), 299, 2018.
  31. Shah, R, Askari, R, Haji, SA, Rashid, A. Mortality and operator experience with vascular access for percutaneous coronary intervention in patients with acute coronary syndromes: A pairwise and network meta-analysis of randomized controlled trials. Int J Cardiol, 248, 114-119, 2017.
  32. Shah, R, Wood, SJ, Khan, SA, Chaudhry, A, Rehan Khan, M, Morsy, MS. High-volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast-induced nephropathy: A meta-analysis of randomized trials. Clin Cardiol, 40 (12), 1242-1246, 2017.
  33. Shah, R, Sabghi, R, Dennis, M. Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy. JAMA Cardiol, 2017.
  34. Shah, R, Morsy, MS, Weiman, DS, Vetrovec, GW. Meta-Analysis Comparing Coronary Artery Bypass Grafting to Drug-Eluting Stents and to Medical Therapy Alone for Left Main Coronary Artery Disease. Am J Cardiol, 120 (1), 63-68, 2017.
  35. Shah, R, Delgado, G, Finks, SW. Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention. Cardiovasc Diagn Ther, 7 (Suppl 2), S66-S68, 2017.
  36. Shah, R, Rashid, A, Hwang, I, Fan, TM, Khouzam, RN, Reed, GL. Meta-Analysis of the Relative Efficacy and Safety of Oral P2Y12 Inhibitors in Patients With Acute Coronary Syndrome. Am J Cardiol, 119 (11), 1723-1728, 2017.
  37. Shah, R. Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration". Circulation, 135 (22), e1101-e1102, 2017.
  38. Shah, R. Bioresorbable vascular scaffolds and late lumen loss. Lancet, 389 (10081), 1796-1797, 2017.
  39. Shah, R, Mattox, A, Khan, MR, Berzingi, C, Rashid, A. Contrast use in relation to the arterial access site for percutaneous coronary intervention: A comprehensive meta-analysis of randomized trials. World J Cardiol, 9 (4), 378-383, 2017.
  40. Shah, R. Optical coherence tomography-guided PCI. Lancet, 389 (10079), 1607, 2017.
  41. Habibi, SE, Shah, R, Berzingi, CO, Melchior, R, Sumption, KF, Jovin, IS. Left main coronary artery stenosis: severity evaluation and implications for management. Expert Rev Cardiovasc Ther, 15 (3), 157-163, 2017.
  42. Shah, R. Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. J Am Coll Cardiol, 69 (3), 363-364, 2017.
  43. Shah, R. Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents. Ann Intern Med, 165 (11), 828-829, 2016.
  44. Shah, R, Rashid, A. Stroke risk from manual aspiration thrombectomy during primary percutaneous coronary intervention: An updated comprehensive meta-analysis of randomized controlled trials. Int J Cardiol, 222, 636-8, 2016.
  45. Shah, R, Berzingi, C, Mumtaz, M, Jasper, JB, Goswami, R, Morsy, MS, Ramanathan, KB, Rao, SV. Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. Am J Cardiol, 118 (10), 1466-1472, 2016.
  46. Shah, R, Matin, K, Rogers, KC, Rao, SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv, 2016.
  47. Shah, R, Rao, SV. Reply: The Hidden Players. JACC Cardiovasc Interv, 9 (18), 1973, 2016.
  48. Shah, R, Rogers, KC, Ahmed, AJ, King, BJ, Rao, SV. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv, 9 (13), 1313-20, 2016.
  49. Shah, R. Optimum technique to reduce risk of stent thrombosis. Lancet, 388 (10040), 127, 2016.
  50. Shah, R, Ahmed, AJ. Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. JACC Cardiovasc Interv, 9 (14), 1517-8, 2016.
  51. Shah, R, Ramos-Bondy, B, Mizeracki, A. Risk of stent thrombosis with bioresorbable vascular scaffolds. Lancet, 387 (10031), 1903, 2016.
  52. Shah, R, Rashid, A, Mizeracki, A. An Elderly Unresponsive Patient. JAMA, 315 (17), 1896-7, 2016.
  53. Shah, R, Khan, MR, Holt, LC. An Elderly Patient With Palpitation and a Negative Nuclear Stress Test Result. JAMA Intern Med, 176 (4), 542-4, 2016.
  54. Shah, R, Qualls, Z. Diaphragmatic stimulation caused by cardiac resynchronization treatment. CMAJ, 2016.
  55. Shah, R, John, E, Fan, TH, Ruff, G, Rehan Khan, M, Holt, LC. A Patient with Metastatic Small-Cell Lung Cancer and Giant Right Ventricular Mass. Echocardiography, 33 (3), 491-3, 2016.
  56. Shah R. Invasive strategy in acute coronary syndrome. Lancet, 387 (387), 2503, 2016.
  57. Rao SV, Shah R. The Fuzzy Math of Anticoagulation and Access Site: When 1 + 1 Does Not Always Equal 2 (Editorial).. JACC Cardiovascular interventions., 2016.
  58. Shah, R. Bivalirudin in Acute Coronary Syndromes. N Engl J Med, 374 (3), 285, 2016.
  59. Shah, R, Rogers, KC, Matin, K, Askari, R, Rao, SV. An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention. Am Heart J, 171 (1), 14-24, 2016.
  60. Shah, R, Gardner, JD. Radial versus femoral access for cardiac catheterisation. Lancet, 386 (10011), 2392-3, 2015.
  61. Shah, R, Berzingi, C, Fan, TH, Askari, R, Khan, MR. Cocaine-Induced Acute Aortic Dissection. J Emerg Med, 49 (3), e87-9, 2015.
  62. Shah, R. Bivalirudin versus heparin use for patients undergoing PPCI. Lancet, 385 (9982), 2045, 2015.
  63. Shah, R. β blockers in patients with heart failure and atrial fibrillation. Lancet, 385 (9978), 1618, 2015.
  64. Shah, R, Khan, MR, Fan, TH, Ruff, G, Ramanathan, KB. An 81-year-old man with an abnormal right-sided heart shadow on chest radiograph. Chest, 147 (2), e52-5, 2015.
  65. Shah, R, Deam, AG. Wide complex tachycardia in a patient with a family history of sudden death. JAMA Intern Med, 175 (1), 128-31, 2015.
  66. Shah, R, Slomka, T, Rogers, KC. Dual antiplatelet treatment after stenting. Lancet, 385 (9965), 326, 2015.
  67. Shah, R. Fractional flow reserve-guided PCI. N Engl J Med, 372 (1), 94-5, 2015.